Trial intelligence / Profile preview

XueZhiKang vs. Simvastatin on Fatigue

NCT01686451Phase 4Completed

Sponsor
Wenzhou Medical University
Start
Aug 2012
Primary completion
Sep 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Xuezhikang in dyslipidemia, sponsored by Wenzhou Medical University. Started Aug 2012; status: completed.

02

Drugs

Xuezhikang
03

Conditions

dyslipidemia

Beyond the preview

Go deeper on NCT01686451.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01686451.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call